Skip to main content

AbCellera Biologics Inc 10-Q for FY2023 Q1

AbCellera Biologics Inc. (ABCL)

10-Q 2023-05-04 For: 2023-03-31
View Original
Added on April 08, 2026

About this 10-Q

AbCellera Biologics Inc filed this 10-Q on May 4, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).

Headline figures

Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$12.19M
down 96.1% from $316.58M a year earlier
Net loss
$40.11M
compared with net income of $168.57M a year earlier
Diluted EPS
-$0.14
compared with $0.54 a year earlier